Table 3: Treatment duration per therapy and treatment line (months).
|
|
Abiraterone |
Cabazitaxel |
Docetaxel |
Enzalutamide |
||||||||
|
Therapy line (n in line) |
N |
Median |
r-Mean |
N |
Median |
r-Mean |
N |
Median 95% CI |
r-Mean |
N |
Median |
r-Mean |
|
1st line (n=447) |
216 |
8.3 |
5.1 |
2 |
1.2 |
1.2 |
169 |
3.5 |
3.6 |
60 |
3.7 |
4.5 |
|
2nd line (n=216) |
106 |
7.4 |
4.7 |
13 |
4.8 |
4.5 |
50 |
3 |
3.0 |
47 |
2.9 |
3.9 |
|
3rd line (n=105) |
37 |
3.3 |
3.9 |
13 |
2.8 |
3.3 |
14 |
3.7 |
3.4 |
41 |
2.9 |
4.3 |
|
4th line (n=52) |
16 |
3.7 |
3.8 |
8 |
2.1 |
2.5 |
6 |
4.9 |
4.2 |
22 |
1.8 |
3.7 |